Last reviewed · How we verify

Azelastine , fluticasone — Competitive Intelligence Brief

Azelastine , fluticasone (Azelastine , fluticasone) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antihistamine and corticosteroid combination. Area: Allergy/Immunology.

marketed Antihistamine and corticosteroid combination H1 receptor (azelastine); glucocorticoid receptor (fluticasone) Allergy/Immunology Small molecule Live · refreshed every 30 min

Target snapshot

Azelastine , fluticasone (Azelastine , fluticasone) — University of Dundee. Azelastine is a selective H1-receptor antagonist and fluticasone is a corticosteroid that together reduce nasal inflammation and allergic responses.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Azelastine , fluticasone TARGET Azelastine , fluticasone University of Dundee marketed Antihistamine and corticosteroid combination H1 receptor (azelastine); glucocorticoid receptor (fluticasone)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antihistamine and corticosteroid combination class)

  1. Bausch & Lomb Incorporated · 1 drug in this class
  2. University of Dundee · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Azelastine , fluticasone — Competitive Intelligence Brief. https://druglandscape.com/ci/azelastine-fluticasone. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: